Telemedicine is fastest growing segment fueling the growth of Visual Impairment market

 

Visual Impairment Market

The visual impairment market is estimated to be valued at US$ 5511.15 Mn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

 

Market Overview:

 

The visual impairment market consists of technologies and devices that assist people with visual impairments in their daily lives. This includes braille displays and notetakers, magnifiers,Braille printers, screen magnification software, and voice assistance software. These products help the visually impaired community in navigation, reading, writing and other tasks. With rising cases of chronic eye diseases and visual disorders due to aging population and changing lifestyle factors, the demand for visual assistance devices is growing significantly.

 

Market Dynamics:

 

Rising geriatric population: Visual impairment is more common among the geriatric population. According to the WHO, the number of people aged 65 years and older is expected to rise from 703 million in 2019 to 1.5 billion in 2050. As the geriatric population is more susceptible to eye disorders like age-related macular degeneration, diabetic retinopathy, and glaucoma, the demand for visual assistance devices is expected to grow markedly over the forecast period.

 

Growing cases of myopia: Short-sightedness or myopia has become a major global eye problem. According to a study published in the British Journal of Ophthalmology, the prevalence of myopia has increased significantly from 1990 to 2020, owing to lifestyle and environmental factors. This has fueled the adoption of visual assistance devices like magnifiers and screen readers to support daily activities.

 

SWOT Analysis

 

Strength: The visual impairment market has a large customer base globally as the prevalence of visual impairment is increasing. Technological advancements have led to creation of innovative products to assist the visually impaired. Rising awareness about products available is driving greater adoption of visual impairment assisting devices.

Weakness: High costs associated with treatment and assistive devices limits their adoption in low and middle income countries. Lack of specialized professionals for guidance on available treatment options is a challenge faced.

Opportunity: Untapped growth opportunities exist in developing nations due to increasing awareness and improving access to treatment and products. Launch of affordable devices specifically designed for needs in these regions can boost market revenues.

Threats: Threat from alternative technologically advanced products. Slow regulatory approvals can delay product launches.

 

Key Takeaways:

 

The Global Visual Impairment Market Share is expected to witness high growth, exhibiting CAGR of 10% over the forecast period, due to increasing prevalence of visual impairment disorders among the aging population. As per WHO, at least 2.2 billion people have vision impairment or blindness, of whom at least 1 billion have a vision impairment that could have been prevented or is yet to be addressed.

 

Regional analysis:

 

North America dominates the global visual impairment market supported by availability of advanced treatment options and devices in the region. However, Asia Pacific is expected exhibit fastest growth owing to improving access to healthcare infrastructure and focus of key players to tap into opportunities in developing nations. China, India and Southeast Asian countries will be major revenue generators for the visual impairment market in Asia Pacific.

 

Key players:

 

Key players operating in the visual impairment market are Adaptivation, Inc., AbleNet, Inc., Amedia Corporation, Access Ingenuity, LVI Low Vision International, American Thermoform, Cambium Learning, Dolphin Computer Access Ltd., HumanWare Group, ViewPlus, and VFO. These companies are focused on developing innovative products catering to specific needs of patients and expanding access through affiliations and subsidized access programs.


Get More Insights Here

https://ceocolumn.com/tech/what-are-field-programmable-gate-arrays-fpgas/

https://www.newswirestats.com/visual-impairment-market-size-share-growth-outlook-2023/

Comments

Post a Comment

Popular posts from this blog

"Global Heparin Market: Current Trends and Future Prospects"

Image
  Heparin, a crucial anticoagulant, has been a mainstay in the pharmaceutical industry for many years. It plays a pivotal role in preventing and treating conditions such as deep vein thrombosis, pulmonary embolism, and various cardiovascular diseases. As we delve into the current state of the heparin market, we will explore the trends, challenges, and opportunities that shape this vital segment of the pharmaceutical industry. Market Overview: The global heparin market has experienced steady growth over the years, driven by an aging population, increasing cases of cardiovascular diseases, and a rising awareness of the importance of anticoagulants in healthcare. Heparin is available in various forms, including unfractionated heparin (UFH) and low molecular weight heparin (LMWH), each with its own set of applications and market dynamics. Trends: 1.      Rising Demand for LMWH : Low molecular weight heparin is gaining popularity due to its ease of administr...
Read more

"Advancements in Cystic Fibrosis Treatment: A Comprehensive Market Analysis"

Image
  The cystic fibrosis market has seen significant advancements and changes in recent years. Cystic fibrosis is a genetic disorder that affects the lungs and digestive system, leading to thick and sticky mucus production that can cause serious respiratory and digestive complications. The introduction of new therapies and treatments, such as CFTR modulators, has revolutionized the management of cystic fibrosis, offering hope and improved quality of life for patients. These drugs target the underlying genetic mutations responsible for the condition, helping to alleviate symptoms and slow disease progression. However, challenges remain in the cystic fibrosis market . Access to these ground-breaking therapies can be limited due to high costs, and ongoing research is needed to develop treatments for all genetic mutations associated with the disease. Additionally, the market continues to evolve as new therapies and innovations emerge. Collaborative efforts between pharmaceutical compani...
Read more

"Advancements in Thyroid Cancer Drugs Market: A Comprehensive Analysis"

Image
  Thyroid cancer is a relatively rare but potentially life-threatening condition that affects the thyroid gland. It has been on the radar of medical researchers and pharmaceutical companies for quite some time, leading to significant advancements in the development of thyroid cancer drugs. In this blog, we will explore the latest developments in the thyroid cancer drugs market and how they are shaping the landscape of treatment options for thyroid cancer patients. 1.      Targeted Therapies: One of the most notable advancements in thyroid cancer treatment is the emergence of targeted therapies. These drugs are designed to specifically target cancer cells, sparing healthy cells and reducing side effects. Some targeted therapies approved for thyroid cancer include Sorafenib and Lenvatinib, which have shown promise in slowing down tumor growth and improving patient outcomes. 2.      Immunotherapy: Immunotherapy has gained significant at...
Read more